Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma.

已完结 10 由达姆发布于 2026/3/24 14:53:10

DOI:10.1056/nejmoa2513918
作者：Guo-Ming Shi,Xiao-Yong Huang,Fei Liang,Xiao Liang,Rui Dong,Qing-Hai Ye,Qiang Gao,Yuan Ji,Zheng-Ping Yu,Wen-Long Zhai,Jia-Cheng Lu,Xiao-Wu Li,Fu-Bao Liu,Kui Wang,Wei Yang,Jia-Lin Zhang,Zhi-Qiang Hu,Shu
文献类型：期刊论文
补充材料：只需要正文

New England Journal of Medicine (NEJM)

Abstract：BACKGROUND No neoadjuvant treatment has been considered to be standard therapy for patients with resectable intrahepatic cholangiocarcinoma with high-risk factors for recurrence. The GOLP r

应助信息

1天前

Book学术机器人

f384d4c2210911f1a40f34735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/3/24 14:53:10 Book学术AI机器人已找到文献并上传

2026/3/24 14:53:10 Book学术AI机器人收到请求，开始寻找文献

2026/3/24 14:53:10 已向机器人发送请求

1天前

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierResearch progress on emotion recognition based on electroencephalogram signals